Showing results (1601-1610 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|February 7, 2009
Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoidWen Jiang, Wentao Deng, Sarah K Bailey, et al.Cancer Biology & Therapy|February 7, 2009
Fenugreek: a naturally occurring edible spice as an anticancer agentShabana Shabbeer, Michelle Sobolewski, Ravi Kumar Anchoori, et al.Cancer Biology & Therapy|April 6, 2010
Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesisJun Yang, Shuqin Chen, Xuan Huang, et al.Cancer Biology & Therapy|April 29, 2010
β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1Dong Zhang, Qing-Yong Ma, Heng-Tong Hu, et al.Cancer Biology & Therapy|April 21, 2010
The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reductionJinrong Cheng, Yue Wu, James L Mohler, et al.Cancer Biology & Therapy|April 21, 2010
Downregulation of voltage-dependent anion channel-1 expression by RNA interference prevents cancer cell growth in vivoInbar Koren, Ziv Raviv, Varda Shoshan-BarmatzCancer Biology & Therapy|April 21, 2010
The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21Deok-Soo Son, Andrew J Wilson, Angelika K Parl, et al.Cancer Biology & Therapy|August 7, 2009
The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitorJose A Gomez, Weiyon Sun, Vivian Gama, et al.Cancer Biology & Therapy|April 8, 2010
Biomarkers for ovarian cancer detection and therapySonia Dutta, Feng-qiang Wang, Adrien Phalen, et al.Cancer Biology & Therapy|September 29, 2009
High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)Jieru Meng, Henry Peng, Bingbing Dai, et al.Pageof 388